Real-World watch: tracking a Crohn's disease Drug's Long-Term performance
NCT ID NCT04002180
Summary
This study is observing patients with moderate to severe Crohn's disease who are already being treated with the drug Entyvio (vedolizumab) in their regular doctor's care. The main goal is to collect long-term information on the drug's safety and how well it works to control the disease in a real-world setting. It is an observational study in Japan, meaning researchers are watching and recording outcomes but not changing the treatment patients receive.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Takeda Selected Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.